Emergent BioSolutions Inc
EBS6.020USD
+0.390+6.93%
Horário de mercado （ET）Cotações atrasadas em 15 min
328.09MValor de mercado
PerdaP/L TTM
Mais detalhes de Emergent BioSolutions Inc Empresa
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.
Informações da empresa
Código da empresaEBS
Nome da EmpresaEmergent BioSolutions Inc
Data de listagemNov 15, 2006
CEOMr. Joseph C. (Joe) Papa
Número de funcionários900
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 15
Endereço300 Professional Dr
CidadeGAITHERSBURG
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal20879
Telefone12406313200
Sitehttps://emergentbiosolutions.com/
Código da empresaEBS
Data de listagemNov 15, 2006
CEOMr. Joseph C. (Joe) Papa
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
85.27K
+67.63%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
68.39K
+1061.66%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
68.25K
+101.64%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
66.14K
-10.60%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
Por RegiãoUSD
Nome
Receita
Proporção
Non-U.S Government
143.40M
64.54%
U.S.Government
78.80M
35.46%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
Distribuição de ações
Atualizado em: qui, 22 de mai
Atualizado em: qui, 22 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
Tipos de investidores
Investidores
Proporção
Investment Advisor
26.89%
Investment Advisor/Hedge Fund
20.51%
Hedge Fund
14.34%
Research Firm
4.30%
Individual Investor
3.04%
Pension Fund
1.04%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.17%
Venture Capital
0.16%
Other
28.88%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
443
38.62M
71.16%
-7.77M
2025Q1
472
38.22M
70.45%
-8.61M
2024Q4
475
36.31M
66.90%
-8.91M
2024Q3
485
33.46M
61.86%
-11.26M
2024Q2
503
32.16M
60.76%
-21.31M
2024Q1
512
37.52M
71.59%
-17.68M
2023Q4
531
43.49M
83.79%
-11.00M
2023Q3
581
43.88M
84.66%
-15.71M
2023Q2
596
48.59M
93.79%
-8.52M
2023Q1
682
47.08M
93.36%
-12.05M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
3.21M
5.92%
+13.30K
+0.42%
Mar 31, 2025
Millennium Management LLC
2.50M
4.61%
+1.02M
+68.87%
Mar 31, 2025
American Century Investment Management, Inc.
2.30M
4.23%
+159.91K
+7.48%
Mar 31, 2025
State Street Global Advisors (US)
1.71M
3.15%
-253.01K
-12.88%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.60M
2.94%
+492.58K
+44.62%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.58M
2.92%
-61.06K
-3.71%
Mar 31, 2025
Marshall Wace LLP
1.16M
2.13%
-170.78K
-12.85%
Mar 31, 2025
Palisade Capital Management, LLC
1.14M
2.1%
+202.86K
+21.61%
Mar 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.05%
--
--
Mar 31, 2025
Qube Research & Technologies Ltd
1.09M
2%
+271.55K
+33.29%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Harbor Human Capital Factor US Small Cap ETF
0.15%
Invesco RAFI US 1500 Small-Mid ETF
0.14%
SPDR S&P Biotech ETF
0.13%
Federated Hermes MDT Small Cap Core ETF
0.1%
Pacer US Small Cap Cash Cows ETF
0.09%
iShares Micro-Cap ETF
0.08%
Avantis US Small Cap Value ETF
0.08%
Direxion Daily S&P Biotech Bull 3X Shares
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Avantis US Small Cap Equity ETF
0.04%
Ver Mais
Harbor Human Capital Factor US Small Cap ETF
Proporção0.15%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.14%
SPDR S&P Biotech ETF
Proporção0.13%
Federated Hermes MDT Small Cap Core ETF
Proporção0.1%
Pacer US Small Cap Cash Cows ETF
Proporção0.09%
iShares Micro-Cap ETF
Proporção0.08%
Avantis US Small Cap Value ETF
Proporção0.08%
Direxion Daily S&P Biotech Bull 3X Shares
Proporção0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.05%
Avantis US Small Cap Equity ETF
Proporção0.04%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
